Literature DB >> 22931505

Chemokine receptor antagonists.

James Pease1, Richard Horuk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22931505     DOI： 10.1021/jm300682j

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  28 in total

1.  Intracellular allosteric antagonism of the CCR9 receptor.

Authors:  Christine Oswald; Mathieu Rappas; James Kean; Andrew S Doré; James C Errey; Kirstie Bennett; Francesca Deflorian; John A Christopher; Ali Jazayeri; Jonathan S Mason; Miles Congreve; Robert M Cooke; Fiona H Marshall
Journal:  Nature       Date:  2016-12-07       Impact factor: 49.962

2.  Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists.

Authors:  Nicholas Kindon; Glen Andrews; Andrew Baxter; David Cheshire; Paul Hemsley; Timothy Johnson; Yu-Zhen Liu; Dermot McGinnity; Mark McHale; Antonio Mete; James Reuberson; Bryan Roberts; John Steele; Barry Teobald; John Unitt; Deborah Vaughan; Iain Walters; Michael J Stocks
Journal:  ACS Med Chem Lett       Date:  2017-09-01       Impact factor: 4.345

3.  In-silico guided discovery of novel CCR9 antagonists.

Authors:  Xin Zhang; Jason B Cross; Jan Romero; Alexander Heifetz; Eric Humphries; Katie Hall; Yuchuan Wu; Sabrina Stucka; Jing Zhang; Haoqun Chandonnet; Blaise Lippa; M Dominic Ryan; J Christian Baber
Journal:  J Comput Aided Mol Des       Date:  2018-03-26       Impact factor: 3.686

Review 4.  What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?

Authors:  Irina Kufareva; Martin Gustavsson; Yi Zheng; Bryan S Stephens; Tracy M Handel
Journal:  Annu Rev Biophys       Date:  2017-05-22       Impact factor: 12.981

Review 5.  CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV.

Authors:  Michelle B Kim; Kyle E Giesler; Yesim A Tahirovic; Valarie M Truax; Dennis C Liotta; Lawrence J Wilson
Journal:  Expert Opin Investig Drugs       Date:  2016-12       Impact factor: 6.206

Review 6.  Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain.

Authors:  Zhi-Jun Zhang; Bao-Chun Jiang; Yong-Jing Gao
Journal:  Cell Mol Life Sci       Date:  2017-04-07       Impact factor: 9.261

7.  A synthetic bivalent ligand of CXCR4 inhibits HIV infection.

Authors:  Yan Xu; Srinivas Duggineni; Stephen Espitia; Douglas D Richman; Jing An; Ziwei Huang
Journal:  Biochem Biophys Res Commun       Date:  2013-05-18       Impact factor: 3.575

Review 8.  New treatment options for alcoholic hepatitis.

Authors:  Saggere Muralikrishna Shasthry; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

9.  Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?

Authors:  Bin Gao; Mingjiang Xu
Journal:  Gut       Date:  2014-02-10       Impact factor: 23.059

10.  CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice.

Authors:  Timothy Sullivan; Zhenhua Miao; Daniel J Dairaghi; Antoni Krasinski; Yu Wang; Bin N Zhao; Trageen Baumgart; Linda S Ertl; Andrew Pennell; Lisa Seitz; Jay Powers; Ruiping Zhao; Solomon Ungashe; Zheng Wei; Landin Boring; Chia-Lin Tsou; Israel Charo; Robert D Berahovich; Thomas J Schall; Juan C Jaen
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.